Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TNYA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
17 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 58 days ago
Red flags: 0
101 filers reported a long position in TNYA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $5.2M | 7.1M | -16.3% |
| MILLENNIUM MANAGEMENT LLC | $4.8M | 6.4M | +17.8% |
| CITADEL ADVISORS LLC | $3.4M | 4.6M | +8.7% |
| RENAISSANCE TECHNOLOGIES LLC | $3.2M | 4.3M | +15.3% |
| BlackRock, Inc. | $3M | 4M | +8.2% |
| Empery Asset Management, LP | $2.9M | 3.9M | -9.9% |
| MARSHALL WACE, LLP | $2.6M | 3.5M | +29.5% |
| GSA CAPITAL PARTNERS LLP | $2M | 2.7M | +148.8% |
| Burkehill Global Management, LP | $1.5M | 2M | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $1.4M | 1.8M | +17.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.